AOD-53724

N/A

Report date: 2022/12/05 09:34:10

Base Information

Drug NameAOD-53724
Drug Alias NameAOD-53724
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCoronavirus spike glycoprotein inhibitorsviral membrane fusion inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Pathogenic Biology Chinese Academy Of Medical SciencesChengdu Aoda Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Aoda Biotechnology Co LtdChengdu Shengnuo Biopharm Co Ltd
Inactive CompaniesChengdu Shengnuo Biotechnology Co Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A